Helmut
★★★
avatar
Homepage
Vienna, Austria,
2021-01-19 18:27
(1572 d 23:09 ago)

Posting: # 22183
Views: 2,021
 

 FDA: ANDA during COVID-19 pandemic [BE/BA News]

Post reply
Dear all,

last Friday the FDA’s CDER/OGD published a new guidance

Protecting Participants in
Bioequivalence Studies for
Abbreviated New Drug
Applications During the COVID-19
Public Health Emergency

—
Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
 
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
148 visitors (0 registered, 148 guests [including 9 identified bots]).
Forum time: 18:37 CEST (Europe/Vienna)

Lack of clarity is always a sign of dishonesty.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5